UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report

Journal of thoracic oncology, 2019-05, Vol.14 (5), p.933-939

2019

Volltextzugriff (PDF)

Clinical significance of the cachexia index in patients with small cell lung cancer

BMC cancer, 2021-05, Vol.21 (1), p.563-563, Article 563

2021

Volltextzugriff (PDF)

Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma

British journal of haematology, 2023-09, Vol.202 (6), p.e54-e57

2023

Volltextzugriff (PDF)

The Endothelial Activation and Stress Index (EASIX) score is an independent prognostic factor in patients with diffuse large B-cell lymphoma

BMC cancer, 2022-07, Vol.22 (1), p.1-816, Article 816

2022

Volltextzugriff (PDF)

Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B‐cell lymphoma

Journal of cachexia, sarcopenia and muscle, 2021-12, Vol.12 (6), p.2211-2219

2021

Volltextzugriff (PDF)

Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

Journal of cachexia, sarcopenia and muscle, 2016-12, Vol.7 (5), p.567-576

2016

Volltextzugriff (PDF)

Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma

BMC cancer, 2020-05, Vol.20 (1), p.439-10, Article 439

2020

Volltextzugriff (PDF)

Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study

Journal of clinical oncology, 2009-12, Vol.27 (35), p.6027-6032

2009

Volltextzugriff (PDF)

Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma

BMC cancer, 2023-11, Vol.23 (1), p.1-1071, Article 1071

2023

Volltextzugriff (PDF)

Clinical impact of prognostic nutritional index in diffuse large B cell lymphoma

Annals of hematology, 2019-02, Vol.98 (2), p.401-411

2019

Volltextzugriff (PDF)

The novel HLA‐B40:489 allele identified in a Korean hematopoietic stem cell donor

HLA, 2021-12, Vol.98 (6), p.547-548

2021

Volltextzugriff (PDF)

MicroRNAs, genomic instability and cancer

International journal of molecular sciences, 2014-08, Vol.15 (8), p.14475-14491

2014

Volltextzugriff (PDF)

Prognostic value of metabolic tumor volume on PET / CT in primary gastrointestinal diffuse large B cell lymphoma

Cancer science, 2012-03, Vol.103 (3), p.477-482

2012

Volltextzugriff (PDF)

Randomized Trial of Myeloablative Conditioning Regimens: Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine

Journal of clinical oncology, 2013-02, Vol.31 (6), p.701-709

2013

Volltextzugriff (PDF)

On the ideality factor of the radiative recombination current in semiconductor light-emitting diodes

Applied physics letters, 2016-07, Vol.109 (3)

2016

Volltextzugriff (PDF)

Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement

Annals of hematology, 2012-05, Vol.91 (5), p.697-703

2012

Volltextzugriff (PDF)

Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling

Cancers, 2021-04, Vol.13 (9), p.2105

2021

Volltextzugriff (PDF)

Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive‐stage disease small cell lung cancer: Results from a randomized controlled trial

Thoracic cancer, 2020-01, Vol.11 (1), p.62-71

2020

Volltextzugriff (PDF)

Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats

American journal of physiology. Renal physiology, 2012-05, Vol.302 (9), p.F1141-F1150

2012

Volltextzugriff (PDF)

PB2678: THE PROGNOSTIC SIGNIFICANCE OF CONTROLLING NUTRITIONAL STATUS AND SARCOPENIA IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e39820a1-n/a

2023

Volltextzugriff (PDF)

Glutamine protects against cisplatin-induced nephrotoxicity by decreasing cisplatin accumulation

Journal of pharmacological sciences, 2015-01, Vol.127 (1), p.117-126

2015

Volltextzugriff (PDF)

Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy

Thrombosis journal, 2023-06, Vol.21 (1), p.63-63, Article 63

2023

Volltextzugriff (PDF)

Low pre‐treatment nutritional index is significantly related to poor outcomes in small cell lung cancer

Thoracic cancer, 2018-11, Vol.9 (11), p.1483-1491

2018

Volltextzugriff (PDF)

Lipocalin‐2 as a prognostic biomarker and its association with systemic inflammation in small cell lung cancer

Thoracic cancer, 2024-07, Vol.15 (21), p.1646-1655

2024

Volltextzugriff (PDF)

1 – 25 von 400

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(343)
Mit Volltextzugriff
(333)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(222)
Life Sciences & Biomedicine
(194)
Humans
(149)
Oncology
(124)
Female
(121)
Male
(117)
Middle Aged
(107)
Aged
(100)
Adult
(90)
Prognosis
(58)
Hematology
(48)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(44)
Treatment Outcome
(44)
Original
(40)
Chemotherapy
(37)
Retrospective Studies
(37)
Aged, 80 And Over
(33)
Lung Cancer
(30)
Medicine
(29)
Medicine & Public Health
(29)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report

Clinical significance of the cachexia index in patients with small cell lung cancer

Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma

The Endothelial Activation and Stress Index (EASIX) score is an independent prognostic factor in patients with diffuse large B-cell lymphoma

Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B‐cell lymphoma

Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma

Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study

Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma

Clinical impact of prognostic nutritional index in diffuse large B cell lymphoma

The novel HLA‐B40:489 allele identified in a Korean hematopoietic stem cell donor

MicroRNAs, genomic instability and cancer

Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09

Prognostic value of metabolic tumor volume on PET / CT in primary gastrointestinal diffuse large B cell lymphoma

Randomized Trial of Myeloablative Conditioning Regimens: Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine

On the ideality factor of the radiative recombination current in semiconductor light-emitting diodes

Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement

Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling

Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive‐stage disease small cell lung cancer: Results from a randomized controlled trial

Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats

PB2678: THE PROGNOSTIC SIGNIFICANCE OF CONTROLLING NUTRITIONAL STATUS AND SARCOPENIA IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA

Glutamine protects against cisplatin-induced nephrotoxicity by decreasing cisplatin accumulation

Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy

Low pre‐treatment nutritional index is significantly related to poor outcomes in small cell lung cancer

Lipocalin‐2 as a prognostic biomarker and its association with systemic inflammation in small cell lung cancer

Suchergebnisse filtern